- Filed
- Sep 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Mar 31, 2025 | 2.46B sh |
| Shares Diluted restated | Q2 2025 · Mar 31, 2024 | 28.38M sh |
| Operating Cash Flow | Q2 2025 · Mar 31, 2025 | −$1.09M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2025 | −¥7.95M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −¥2.09M |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $4.92M |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | ¥35.7M |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | ¥32.07M |
| Short Term Investments | Q2 2025 · Mar 31, 2025 | $235K |
| Short Term Investments | Q2 2025 · Mar 31, 2025 | ¥1.7M |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | ¥2.03M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $674K |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | ¥4.89M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | ¥8.09M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | −$167.38M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | −¥1.21B |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | −¥556.57M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −¥224.61M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | −¥643.42M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $183.26M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | ¥1.33B |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | ¥1.34B |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $183.31M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | ¥1.33B |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | ¥1.34B |
| Current Assets | Q2 2025 · Mar 31, 2025 | $6.17M |
| Current Assets | Q2 2025 · Mar 31, 2025 | ¥44.78M |
| Current Assets | Q2 2025 · Sep 30, 2024 | ¥67.64M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $15.93M |
| Total Assets | Q2 2025 · Mar 31, 2025 | ¥115.6M |
| Total Assets | Q2 2025 · Sep 30, 2024 | ¥782.84M |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | ¥0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | ¥0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | ¥0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | ¥0.00 |
| Sga Expense | Q2 2025 · Mar 31, 2025 | $1.64M |
| Sga Expense | Q2 2025 · Mar 31, 2025 | ¥11.93M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | ¥6.93M |
| Net Income | Q2 2025 · Mar 31, 2025 | −$93.39M |
| Net Income | Q2 2025 · Mar 31, 2025 | −¥677.71M |
| Net Income | Q2 2025 · Mar 31, 2024 | ¥387.43M |
| Operating Income | Q2 2025 · Mar 31, 2025 | −$90.76M |
| Operating Income | Q2 2025 · Mar 31, 2025 | −¥658.62M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −¥5.65M |
| Gross Profit | Q2 2025 · Mar 31, 2025 | $592K |
| Gross Profit | Q2 2025 · Mar 31, 2025 | ¥4.3M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | ¥4.19M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2025 | $23.62M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2025 | ¥171.38M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | ¥72.56M |
| Revenue | Q2 2025 · Mar 31, 2025 | $24.21M |
| Revenue | Q2 2025 · Mar 31, 2025 | ¥175.68M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | ¥76.74M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | ¥15K |